Stocktoria
IDEXX LABORATORIES INC /DE IDXX
Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-06-21
IDEXX LABORATORIES INC /DE institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,603,226 | $4.7B | 11.85% |
| Point72 Asset Management, L.P. | 129,284 | $72.6M | 0.16% |
| CITADEL ADVISORS LLC | 128,866 | $72.4M | 0.16% |
| MILLENNIUM MANAGEMENT LLC | 107,046 | $60.1M | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 96,726 | $53.8M | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 48,504 | $27.3M | 0.06% |
| Bridgewater Associates, LP | 10,314 | $5.8M | 0.01% |
| D. E. Shaw & Co., Inc. | 1,074 | $603,470 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.